Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP285802.RAVPRDLoXp2t2E2hnxivHoKp4z5bvDwZ4hAX67kE73NlA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP285802.RAVPRDLoXp2t2E2hnxivHoKp4z5bvDwZ4hAX67kE73NlA130_assertion type Assertion NP285802.RAVPRDLoXp2t2E2hnxivHoKp4z5bvDwZ4hAX67kE73NlA130_head.
- NP285802.RAVPRDLoXp2t2E2hnxivHoKp4z5bvDwZ4hAX67kE73NlA130_assertion description "[The methylation frequencies of CHFR, DAP-kinase, E-cadherin, hMLH1, p16, RASSF1A, and RUNX3 genes were 16.2%, 21.4%, 27.0%, 8.1%, 24.3%, 27.0%, and 56.8%, respectively, in primary biliary tract carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285802.RAVPRDLoXp2t2E2hnxivHoKp4z5bvDwZ4hAX67kE73NlA130_provenance.
- NP285802.RAVPRDLoXp2t2E2hnxivHoKp4z5bvDwZ4hAX67kE73NlA130_assertion evidence source_evidence_literature NP285802.RAVPRDLoXp2t2E2hnxivHoKp4z5bvDwZ4hAX67kE73NlA130_provenance.
- NP285802.RAVPRDLoXp2t2E2hnxivHoKp4z5bvDwZ4hAX67kE73NlA130_assertion SIO_000772 15471559 NP285802.RAVPRDLoXp2t2E2hnxivHoKp4z5bvDwZ4hAX67kE73NlA130_provenance.
- NP285802.RAVPRDLoXp2t2E2hnxivHoKp4z5bvDwZ4hAX67kE73NlA130_assertion wasDerivedFrom befree-20150227 NP285802.RAVPRDLoXp2t2E2hnxivHoKp4z5bvDwZ4hAX67kE73NlA130_provenance.
- NP285802.RAVPRDLoXp2t2E2hnxivHoKp4z5bvDwZ4hAX67kE73NlA130_assertion wasGeneratedBy ECO_0000203 NP285802.RAVPRDLoXp2t2E2hnxivHoKp4z5bvDwZ4hAX67kE73NlA130_provenance.